Lornoxicam

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

Non-steroidal anti-inflammatory drug from the Piroxicame group.

Indication
This section has been translated automatically.

Pain therapy for arthritis, including rheumatoid arthritis, ankylosing spondylitis, pain in arthrosis or other underlying diseases.

Pregnancy/nursing period
This section has been translated automatically.

Contraindicated (insufficient data on use in pregnancy; substance passes into breast milk in animal experiments).

Dosage and method of use
This section has been translated automatically.

  • Tbl.: 3-4 times/day 4 mg or 2 times/day 8 mg p.o. (to be taken before a meal with sufficient liquid). Max. Daily dose 16 mg, in patients with liver or kidney dysfunction 12 mg.
  • Suppositories: 2 times/day 1 supp. (12 mg), maximum daily dose: 24 mg.

Undesirable effects
This section has been translated automatically.

  • Common (10-20% of patients with short-term treatment and 20-35% with long-term treatment): Gastrointestinal symptoms such as heartburn, nausea, vomiting, abdominal pain.
  • Rarely (1-2% of patients): cutaneous side effects such as maculopapular exanthema, urticaria, ecchymosis) etc. Rarely (about 5% of patients): tiredness, paresthesia, dizziness.

Contraindication
This section has been translated automatically.

Application for Pat < 18 yrs (insufficient data). Hypersensitivity to the substance or cross-reactions to other non-steroidal anti-inflammatory drugs (including acetylsalicylic acid). Active stomach or intestinal ulcers, gastrointestinal bleeding. Severe liver or kidney failure.

Preparations
This section has been translated automatically.

Telos

Note(s)
This section has been translated automatically.

Remember! The ability to react in road traffic and when operating machines may be impaired!

Incoming links (1)

Oxicame;

Authors

Last updated on: 29.10.2020